Poly Medicure Ltd.
Snapshot View

751.80 +22.80 ▲3.1%

18 August 2022, 04:01:00 PM
Volume: 2,678

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.polymedicure.com
Market Cap 7,214.50 Cr.
Enterprise Value(EV) 7,320.98 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 14.17 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 53.07 Trailing Twelve Months Ending 2022-06
Industry PE 56.94 Trailing Twelve Months Ending 2022-06
Book Value / Share 116.15 Trailing Twelve Months Ending 2022-06
Price to Book Value 6.47 Calculated using Price: 751.80
Dividend Yield 0.33 Period Ending 2021-03
No. of Shares Subscribed 9.59 Cr. 95,918,392 Shares
FaceValue 5
Company Profile
Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.13%
1 Week
+1.57%
1 Month
-1.75%
3 Month
-3.94%
6 Month
+0.78%
1 Year
-15.80%
2 Year
+87.06%
5 Year
+253.21%
10 Year
+1923.69%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 22.63 34.10 36.03 22.35 21.81 22.76 17.80 22.98 18.94
Return on Capital Employed (%) 26.73 38.77 38.90 25.59 24.37 25.39 22.19 24.43 21.58
Return on Assets (%) 11.75 17.59 18.97 12.64 12.92 13.58 10.27 12.66 12.83

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 112 146 196 229 272 338 381 435 966 1,087
Non Curr. Liab. 34 51 55 49 72 104 119 139 87 63
Curr. Liab. 68 89 113 109 114 123 181 225 215 227
Minority Int.
Equity & Liab. 214 286 364 387 457 565 682 800 1,267 1,377
Non Curr. Assets 120 166 205 217 252 310 352 450 518 593
Curr. Assets 94 120 160 171 205 255 329 350 749 783
Misc. Exp. not W/O
Total Assets 214 286 364 387 457 565 682 800 1,267 1,377

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 260 322 390 412 455 520 611 687 786 960
Other Income 0 1 8 8 14 14 18 18 18 32
Total Income 260 323 398 421 469 535 629 706 805 992
Total Expenditure -207 -247 -304 -325 -362 -398 -480 -521 -570 -756
PBIDT 53 77 94 96 107 136 150 185 235 236
Interest -7 -9 -10 -10 -9 -12 -14 -20 -11 -2
Depreciation -13 -14 -19 -21 -24 -29 -37 -41 -48 -55
Taxation -10 -19 -23 -18 -20 -26 -35 -30 -44 -45
Exceptional Items 10 20
PAT 23 44 62 47 55 69 64 94 133 134
Minority Interest 0
Share Associate 1 1 1 1 1 1 1 2 3 2
Other Related Items
Consolidated Net Profit 24 45 62 48 55 71 65 96 136 136
Adjusted EPS 3 5 7 5 6 8 7 11 14 14

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 33 39 66 63 63 56 75 106 128 119
Cash Fr. Inv. -26 -31 -58 -59 -31 -56 -88 -101 -107 -436
Cash Fr. Finan. -6 -8 5 -6 -31 0 16 -5 -21 317
Net Change 0 0 13 -2 1 0 3 1 1 0
Cash & Cash Eqvt 1 1 14 12 13 1 4 4 5 5

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 48.76 48.76 48.77 44.88 44.77 44.77 44.76 44.66 53.34
Public 51.24 51.24 51.23 55.12 55.23 55.23 55.24 55.34 46.66
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 04 Aug 2022
Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations 2015 <BR>
Dear Sir/Madam
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations 2015 We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th August 2022 at 232-B 3RD Floor Okhla Industrial Estate Phase-III New Delhi - 110020 approved the following businesses:
a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2022.

b) Allotted 18 050 Equity Shares of Rs. 5 each pursuant to exercise of an option under Employee Stock Option Scheme 2016.

c) Ratification of Remuneration to M/ s. Jai Prakash & Company Cost Accountants appointed as Cost Auditors of the Company for the Financial Year 2022-23 subject to the approval of the shareholders in the forthcoming Annual General Meeting.

d) Resolution for Shareholders approval for re-appointment and remuneration of Mr. Vishal Baid as Sr. President (Sales and Marketing) of the Company in the forthcoming Annual General Meeting.
Thu, 04 Aug 2022
Financial Results(Standalone & Consolidated) For The Quarter Ended 30Th June 2022 In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations 2015
Dear Sir/Madam
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations 2015 We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th August 2022 at 232-B 3RD Floor Okhla Industrial Estate Phase-III New Delhi - 110020 approved the following businesses:
a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2022.
Tue, 02 Aug 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dear Sir/Madam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that an earnings call will be held on Friday 5th August 2022 at 3.00 p.m. (IST) for discussing the Un-Audited Financial Results of the Company for the quarter ended 30th June 2022.Link for joining Dial in and other details of the call are enclosed herewith.ICICI Securities Limited through its representatives along with Companys officials will coordinate the aforesaid meeting.This is for your information and record.Thanking You

Technical Scans View Details >>

Thu, 18 Aug 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,779.08 916.00 -0.5%
Divi's Laboratories Ltd. 99,402.06 3,744.40 -0.1%
Cipla Ltd. 83,298.12 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. 70,326.13 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. 61,347.88 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. 52,831.33 1,564.95 +0.5%
Piramal Enterprises Ltd. 46,812.69 1,961.10 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.51 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 32.01 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-06 33.50 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.51 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.51 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.12 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-06 24.90 1,961.10 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 8.00 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-06 3.88 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.47 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.33 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.29 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-06 1.31 1,961.10 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,961.10 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,961.10 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,961.10 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,961.10 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,961.10 -0.7%

FAQ's On Poly Medicure Ltd.

Can I Buy Poly Medicure Shares now?

What is the Share Price of Poly Medicure?

What is the Relative Strength Index (RSI) Value of Poly Medicure?

What is the Market Capital (MCAP) of Poly Medicure?

What are the key metrics to analyse Poly Medicure?

What is the Price Performance of Poly Medicure?